Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants

By BY CARL ZIMMER, NOAH WEILAND AND SHARON LAFRANIERE from NYT Health The vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases. https://ift.tt/3thE4U2